Story · Medicine & Biotech

Spatial Transcriptomics of TKI Response in Metastatic Clear Cell Renal Cell Carcinoma

1 outlet · first reported by OncoDaily on

Despite advances in the treatment of metastatic clear cell renal cell carcinoma (ccRCC), predicting which patients will respond to tyrosine kinase inhibitors (TKIs) remains challenging. Although immune checkpoint inhibitor-based combinations (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study
    Spatial Transcriptomics of TKI Response in Metastatic Clear Cell Renal Cell Carcinoma

    Despite advances in the treatment of metastatic clear cell renal cell carcinoma (ccRCC), predicting which patients will respond to tyrosine kinase inhibitors (TKIs) remains challenging. Although immune checkpoint inhibitor-based combinations

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.